In vivo gene delivery to immune cells
Current Opinion in Biotechnology · 2024-08 · 88 · 103169
DOI: 10.1016/j.copbio.2024.103169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2024-08. Verfasst von Jamison C Siebart und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. Hauptthemen laut MEDLINE: Gene Transfer Techniques, Genetic Therapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Emory University Winship Cancer Institute, National Science Foundation.
Abstract (Originalsprache)
Immune cell therapies are an emerging class of living drugs that rely on the delivery of therapeutic transgenes to enhance, modulate, or restore cell function, such as those that encode for tumor-targeting receptors or replacement proteins. However, many cellular immunotherapies are autologous treatments that are limited by high manufacturing costs, typical vein-to-vein time of 3-4 weeks, and severe immune-related adverse effects. To address these issues, different classes of gene delivery vehicles are being developed to target specific immune cell subsets in vivo to address the limitations of ex vivo manufacturing, modulate therapeutic responses in situ, and reduce on- and off-target toxicity. The success of in vivo gene delivery to immune cells - which is being tested at the preclinical and clinical stages of development for the treatment of cancer, infectious diseases, and autoimmunity - is paramount for the democratization of cellular immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
- The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Institute…
Förderung
- NCI NIH HHS
- Emory University Winship Cancer Institute
- National Science Foundation
- Aflac Cancer Center
- Peking University
- National Institutes of Health
- International Myeloma Society
- Paula and Rodger Riney Foundation
Zitieren
APA
Siebart, J. C., Chan, C. S., Yao, X., Su, F. Y., & Kwong, G. A. (2024). In vivo gene delivery to immune cells. Current Opinion in Biotechnology, 88, 103169. https://doi.org/10.1016/j.copbio.2024.103169
Vancouver
Siebart JC, Chan CS, Yao X, Su FY, Kwong GA. In vivo gene delivery to immune cells. Current Opinion in Biotechnology. 2024;88:103169. doi:10.1016/j.copbio.2024.103169
BibTeX
@article{Siebart2024,
author = {Siebart, Jamison C and Chan, Ching S and Yao, Xinyi and Su, Fang-Yi and Kwong, Gabriel A},
title = {In vivo gene delivery to immune cells},
journal = {Current Opinion in Biotechnology},
year = {2024},
volume = {88},
pages = {103169},
doi = {10.1016/j.copbio.2024.103169}
}
EUVIMED